Related references
Note: Only part of the references are listed.Anti-dsDNA antibodies induce inflammation via endoplasmic reticulum stress in human mesangial cells
Hui Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Glycogen Synthase Kinase 3β Promotion of Renal Damage Through Activation of the NLRP3 Inflammasome in Lupus-Prone Mice
Jijun Zhao et al.
ARTHRITIS & RHEUMATOLOGY (2015)
Sex-dependent differential activation of NLRP3 and AIM2 inflammasomes in SLE macrophages
Chin-An Yang et al.
RHEUMATOLOGY (2015)
Serum procalcitonin and C-reactive protein for differentiating bacterial infection from disease activity in patients with systemic lupus erythematosus
Jinquan Yu et al.
MODERN RHEUMATOLOGY (2014)
Role of mitochondria ROS generation in ethanol-induced NLRP3 inflammasome activation and cell death in astroglial cells
Silvia Alfonso-Loeches et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
P2X7 Blockade Attenuates Murine Lupus Nephritis by Inhibiting Activation of the NLRP3/ASC/Caspase 1 Pathway
Jijun Zhao et al.
ARTHRITIS AND RHEUMATISM (2013)
K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
Raul Munoz-Planillo et al.
IMMUNITY (2013)
Self Double-Stranded (ds) DNA Induces IL-1β Production from Human Monocytes by Activating NLRP3 Inflammasome in the Presence of Anti-dsDNA Antibodies
Min Sun Shin et al.
JOURNAL OF IMMUNOLOGY (2013)
Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth
Melanie Bruchard et al.
NATURE MEDICINE (2013)
Mycobacterium tuberculosis Triggers Host Type I IFN Signaling To Regulate IL-1β Production in Human Macrophages
Aleksey Novikov et al.
JOURNAL OF IMMUNOLOGY (2011)
A role for mitochondria in NLRP3 inflammasome activation
Rongbin Zhou et al.
NATURE (2011)
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Haitao Wen et al.
NATURE IMMUNOLOGY (2011)
NLRP3 inflammasomes link inflammation and metabolic disease
Dominic De Nardo et al.
TRENDS IN IMMUNOLOGY (2011)
Inflammasomes and autoimmunity
Patrick J. Shaw et al.
TRENDS IN MOLECULAR MEDICINE (2011)
The inflammasomes: mechanisms of activation and function
Eicke Latz
CURRENT OPINION IN IMMUNOLOGY (2010)
Signaling by ROS drives inflammasome activation
Fabio Martinon
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Anti-dsDNA Antibodies Bind to Mesangial Annexin II in Lupus Nephritis
Susan Yung et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1 beta in type 2 diabetes
Seth L. Masters et al.
NATURE IMMUNOLOGY (2010)
Cytokines as therapeutic targets in SLE
Lars Ronnblom et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
Franz G. Bauernfeind et al.
JOURNAL OF IMMUNOLOGY (2009)
Neisseria gonorrhoeae Activates the Proteinase Cathepsin B to Mediate the Signaling Activities of the NLRP3 and ASC-Containing Inflammasome
Joseph A. Duncan et al.
JOURNAL OF IMMUNOLOGY (2009)
IL-17 and the Th17 lineage in systemic lupus erythematosus
Lee Ann Garrett-Sinha et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
Veit Hornung et al.
NATURE IMMUNOLOGY (2008)
Fifty years of anti-ds DNA antibodies: are we approaching journey's end?
D. A. Isenberg et al.
RHEUMATOLOGY (2007)
被撤回的出版物: The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism (Retracted article. See vol. 134, pg. 95, 2019)
G Dasmahapatra et al.
BLOOD (2006)
Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis
B Ostendorf et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Anti-DNA antibodies: a diagnostic and prognostic tool for systemic lupus erythematosus?
P Riboldi et al.
AUTOIMMUNITY (2005)
Morbidity and mortality in systemic lupus erythematosus during a 10-year period -: A comparison of early and late manifestations in a cohort of 1,000 patients
R Cervera et al.
MEDICINE (2003)
Systemic Lupus Erythematosus and Other Autoimmune Diseases from Endogenous and Exogenous Agents: Unifying Theme of Oxidative Stress
Peter Kovacic et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2003)
Use of a new fluorescence immunoassay to detect anti-dsDNA antibodies is more correlated with disease activity and complement than the ELISA method in SLE patients
CY Chen et al.
LUPUS (2003)
Mitochondrial reactive oxygen species in cell death signaling
C Fleury et al.
BIOCHIMIE (2002)
Toll-like receptor-mediated NF-kappa B activation: a phylogenetically conserved paradigm in innate immunity
GL Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
